Skip to main content

Anhedonia

2
Pipeline Programs
4
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
3 programs
2
EndotoxinPhase 11 trial
EndotoxinPhase 11 trial
Positive Virtual Reality TrainingN/A1 trial
Active Trials
NCT03715400Suspended74Est. Jan 2021
NCT05363527Completed40Est. Dec 2025
NCT03848715Completed40Est. Jul 2024
Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With ObesityN/A1 trial
Active Trials
NCT03939676Completed12Est. Dec 2020
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
GET ActivEN/A1 trial
Active Trials
NCT06829953Recruiting75Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsEndotoxin
Angeles TherapeuticsEndotoxin
Oregon TherapeuticsGET ActivE
Cognition TherapeuticsEvaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity
Angeles TherapeuticsPositive Virtual Reality Training

Clinical Trials (5)

Total enrollment: 241 patients across 5 trials

NCT05363527Angeles TherapeuticsEndotoxin

Aging and Reward System Response to Inflammation and Anxiety Study

Start: Mar 2023Est. completion: Dec 202540 patients
Phase 1Completed
NCT03848715Angeles TherapeuticsEndotoxin

Sleep and Healthy Aging Research on Depression for Younger Women

Start: Oct 2019Est. completion: Jul 202440 patients
Phase 1Completed
NCT06829953Oregon TherapeuticsGET ActivE

Get ActivE Study for At-risk Youth

Start: Mar 2025Est. completion: Dec 202675 patients
N/ARecruiting
NCT03939676Cognition TherapeuticsEvaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity

Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity

Start: Oct 2019Est. completion: Dec 202012 patients
N/ACompleted
NCT03715400Angeles TherapeuticsPositive Virtual Reality Training

Mobile Virtual Positive Experiences for Anhedonia

Start: Sep 2018Est. completion: Jan 202174 patients
N/ASuspended

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 241 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.